Iranian Journal of Pathology最新文献

筛选
英文 中文
Clinicopathological Characteristics of Breast Cancer Patients with Equivocal Immunohistochemistry: A Prevalence-Based Statistical Analysis. 免疫组织化学模棱两可的乳腺癌患者的临床病理特征:基于患病率的统计分析。
Iranian Journal of Pathology Pub Date : 2025-01-01 Epub Date: 2025-07-01 DOI: 10.30699/ijp.2025.2045071.3378
Hossein Ayatollahi, Amir Hossein Jafarian, Zahra Pakize Moghadam, Yasamin Ayatollahi, Golnaz Ghayyem Hassankhani, Hassan Mehrad-Majd
{"title":"Clinicopathological Characteristics of Breast Cancer Patients with Equivocal Immunohistochemistry: A Prevalence-Based Statistical Analysis.","authors":"Hossein Ayatollahi, Amir Hossein Jafarian, Zahra Pakize Moghadam, Yasamin Ayatollahi, Golnaz Ghayyem Hassankhani, Hassan Mehrad-Majd","doi":"10.30699/ijp.2025.2045071.3378","DOIUrl":"10.30699/ijp.2025.2045071.3378","url":null,"abstract":"<p><strong>Background & objective: </strong>Although the concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) is generally high for HER2 scores of 3+ and 1+, discrepancies remain in cases scored as IHC 2+. This study aimed to evaluate HER2/neu gene amplification using FISH in breast cancer patients with IHC 2+ and to examine associated clinicopathological characteristics.</p><p><strong>Methods: </strong>This retrospective study included tissue samples from 369 women diagnosed with invasive ductal carcinoma of the breast and an equivocal HER2 IHC score (2+). These samples were further assessed for HER2 gene amplification using FISH. Demographic and clinicopathological data were collected and analyzed.</p><p><strong>Results: </strong>The mean age of patients was 51.6 ± 2.6 years. FISH analysis revealed no HER2 amplification in 72.6% of IHC 2+ cases, while 27.4% demonstrated amplification. HER2 amplification was significantly associated with younger age, higher histological grade, lymph node involvement, larger tumor size, and reduced survival rate. No significant association was observed between HER2 amplification and margin involvement.</p><p><strong>Conclusion: </strong>HER2 amplification is a significant predictor of aggressive tumor behavior and may necessitate targeted therapy. In cases with IHC 2+, both FISH results and relevant clinicopathological features should be considered prior to initiating trastuzumab treatment.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"20 3","pages":"273-279"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144761687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of ADAM10 and CD58 in Acute and Chronic Lymphocytic Leukemia: Influence of Disease Stage and Chemotherapy. 急性和慢性淋巴细胞白血病中ADAM10和CD58的表达:疾病分期和化疗的影响
Iranian Journal of Pathology Pub Date : 2025-01-01 Epub Date: 2025-07-01 DOI: 10.30699/ijp.2025.2060663.3459
Ameer Hamid Kadhim, Muslim Idan Mohsin
{"title":"Expression of ADAM10 and CD58 in Acute and Chronic Lymphocytic Leukemia: Influence of Disease Stage and Chemotherapy.","authors":"Ameer Hamid Kadhim, Muslim Idan Mohsin","doi":"10.30699/ijp.2025.2060663.3459","DOIUrl":"10.30699/ijp.2025.2060663.3459","url":null,"abstract":"<p><strong>Background & objective: </strong>CD58 and ADAM10 have been implicated in leukemia progression and chemoresistance; however, their specific roles in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL), particularly under chemotherapeutic pressure, remain insufficiently characterized. This study aimed to assess the expression of CD58, an immune adhesion molecule, and ADAM10, a metalloproteinase, in ALL and CLL patients undergoing chemotherapy, and to explore their potential involvement in immune evasion, niche-mediated survival, and chemoresistance mechanisms.</p><p><strong>Methods: </strong>Peripheral blood mononuclear cells (PBMCs) were isolated from 50 patients with ALL, 50 with CLL, and 30 healthy controls. Expression levels of CD58 and ADAM10 were analyzed by quantitative reverse transcription PCR (qRT-PCR) and flow cytometry. Chemotherapy regimens included vincristine (VCR), methotrexate (MTX), and doxorubicin (DOXO).</p><p><strong>Results: </strong>ADAM10 mRNA expression was significantly upregulated in ALL patients treated with VCR+MTX (p<0.0001) and DOXO (p=0.001), with corresponding protein overexpression observed in both ALL (p<0.0001) and untreated CLL patients (p<0.0001). A significant difference in ADAM10 levels was noted between ALL and CLL cohorts (p=0.001). CD58 mRNA and protein expression were markedly increased in ALL patients receiving VCR+MTX (p<0.0001), whereas untreated CLL patients exhibited no significant alterations.</p><p><strong>Conclusion: </strong>CD58 and ADAM10 are differentially regulated in ALL under chemotherapy, supporting their roles in immune evasion and microenvironmental survival. The constitutive overexpression of ADAM10 in CLL suggests its involvement in chronic leukemic pathogenesis. These findings highlight CD58 and ADAM10 as potential therapeutic targets for overcoming chemoresistance in lymphoid malignancies.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"20 3","pages":"316-325"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144761691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Epidemiology and MLST-Based Typing of Pandrug-Resistant Acinetobacter baumannii Clinical Isolates in Iraq: A Cross-Sectional Study. 伊拉克全耐药鲍曼不动杆菌临床分离株的分子流行病学和基于mlst的分型:一项横断面研究。
Iranian Journal of Pathology Pub Date : 2025-01-01 Epub Date: 2025-03-10 DOI: 10.30699/ijp.2025.2052426.3412
Hani Hasan Jubair, Marwa Jabbar Mezher, Noor Ayyed Mayea
{"title":"Molecular Epidemiology and MLST-Based Typing of Pandrug-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates in Iraq: A Cross-Sectional Study.","authors":"Hani Hasan Jubair, Marwa Jabbar Mezher, Noor Ayyed Mayea","doi":"10.30699/ijp.2025.2052426.3412","DOIUrl":"10.30699/ijp.2025.2052426.3412","url":null,"abstract":"<p><strong>Background & objective: </strong><i>Acinetobacter baumannii</i> is a globally recognized nosocomial pathogen capable of developing multidrug resistance. This study investigates antibiotic resistance patterns, evaluates common resistance genotypes, and explores the genetic relatedness of PDR <i>A. baumannii</i> clinical isolates from hospitals in the Middle Euphrates region of Iraq.</p><p><strong>Methods: </strong>Fourteen PDR <i>A. baumannii</i> isolates were obtained and subjected to antimicrobial susceptibility testing using the Vitek-2 compact system. Resistance genes were identified via conventional PCR, and clonal relationships were analyzed using multilocus sequence typing (MLST).</p><p><strong>Results: </strong>Among 175 <i>A. baumannii</i> isolates, 8% (14/175) were classified as PDR strains, exhibiting resistance to all tested antibiotics. TEM was the most prevalent resistance gene (50%), followed by CTX-M (43%). SHV, IMP, KPC, OXA-48, and Mcr-1 genes were absent in all PDR isolates. MLST analysis identified five sequence types (STs): ST2, ST218, ST138, ST123, and ST460, with ST2 being the most common (50%).</p><p><strong>Conclusion: </strong>The high prevalence of PDR <i>A. baumannii strains</i> in Iraq highlights the need for enhanced antibiotic surveillance. A comprehensive molecular investigation is necessary to mitigate the spread of these resistant pathogens.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"20 2","pages":"173-180"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12142017/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous miliary Lymphocytoma: A Case Report with Immunohistochemical Findings. 皮肤军事性淋巴细胞瘤:1例免疫组化结果报告。
Iranian Journal of Pathology Pub Date : 2025-01-01 Epub Date: 2025-03-10 DOI: 10.30699/iijp.2024.2025080.3287
Shatila Torabi, Sima Davoodi, Mostafa Izanlu, Pouria Etesamizade, Naser Tayebi Meibodi
{"title":"Cutaneous miliary Lymphocytoma: A Case Report with Immunohistochemical Findings.","authors":"Shatila Torabi, Sima Davoodi, Mostafa Izanlu, Pouria Etesamizade, Naser Tayebi Meibodi","doi":"10.30699/iijp.2024.2025080.3287","DOIUrl":"10.30699/iijp.2024.2025080.3287","url":null,"abstract":"<p><p>Cutaneous pseudolymphomas (PSLs) as lymphocytic infiltrates are benign lesions that clinically and histopathologically mimic lymphomas. Miliarial type lymphocytoma cutis is an uncommon type of pseudolymphoma that is characterized by multiple semi-translucent micropapules on the sun-exposed regions. We present a 61-year-old woman who was admitted to our clinic with diffuse, sand-like, and erythematous micropapules on her face. Microscopic findings revealed nodular lymphoid aggregation, with the germinal center formation consisting of polyclonal lymphoid infiltrate confirmed by Immunohistochemistry (IHC) studies. According to this clinicopathological correlation, the miliarial type pseudolymphoma was confirmed and she was treated with topical corticosteroid ointment with a good response.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"20 2","pages":"235-238"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12142020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of RCC2, Rac1 and p53 Expression in Breast Infiltrating Ductal Carcinoma; An Immunohistochemical Study. 乳腺浸润性导管癌中 RCC2、Rac1 和 p53 表达的意义;一项免疫组化研究。
Iranian Journal of Pathology Pub Date : 2024-01-01 Epub Date: 2023-02-15 DOI: 10.30699/IJP.2024.2014367.3198
Aiat Shaban Hemida, Reham Ahmed Abdelaziz, Moshira Mohammed Abd El-Wahed, Nancy Yousef Asaad, Marwa Mohammed Serag El-Dien, Hend Ali Elshahat Ali
{"title":"Significance of RCC2, Rac1 and p53 Expression in Breast Infiltrating Ductal Carcinoma; An Immunohistochemical Study.","authors":"Aiat Shaban Hemida, Reham Ahmed Abdelaziz, Moshira Mohammed Abd El-Wahed, Nancy Yousef Asaad, Marwa Mohammed Serag El-Dien, Hend Ali Elshahat Ali","doi":"10.30699/IJP.2024.2014367.3198","DOIUrl":"10.30699/IJP.2024.2014367.3198","url":null,"abstract":"<p><strong>Background & objective: </strong>The regulator of chromosome condensation 2 (RCC2) and RAS-related C3 botulinum toxin substrate 1 (Rac1) have been implicated in the promotion of breast cancer cell proliferation and migration. The signaling pathway involving p53/RCC2/Rac1 has been proposed to contribute to the regulation of colon cancer metastasis. However, until now, this pathway has not been thoroughly investigated in breast cancer. This study seeks to explore the influence of immunohistochemical expression and the correlation among RCC2, Rac1, and p53 in breast infiltrating ductal carcinoma (IDC).</p><p><strong>Methods: </strong>Immunostaining was performed on 120 breast IDC specimens using RCC2, Rac1, and p53 antibodies. Statistical analyses were conducted to examine the correlations between these antibodies.</p><p><strong>Results: </strong>A Positive expression of RCC2, Rac1, and p53 was observed in 116 (96.7%), 120 (100%), and 33 (27.5%) of the breast cancer cases, respectively. RCC2, Rac1, and p53 demonstrated association with poor prognostic parameters such as frequent mitoses, high Ki-67 status, positive lymphovascular invasion (LVI), and advanced tumor stage. A highly significant direct correlation was found between each immunohistochemical marker and the other two markers. Shorter overall survival was linked to multifocal tumors (<i>P</i>=0.017), advanced tumor stage (T3) (<i>P</i>=0.010), Luminal B subtype (<i>P</i>=0.015), progressive disease (<i>P</i>=0.003), positive Her2neu status (<i>P</i>=0.008), and metastasis to distant organs (<i>P</i><0.001). However, RCC2, Rac1, and p53 did not exhibit a significant association with overall survival.</p><p><strong>Conclusion: </strong>The high expression levels of RCC2, Rac1, and p53 in breast IDC suggest their potential role in tumor behavior. The association of RCC2 and Rac1 with poor prognostic parameters may serve as predictive indicators for aggressive tumors, thus implying that targeted therapy could be beneficial in the treatment of breast cancer.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 2","pages":"177-192"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11304461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effective Ki-67 Reduction by Pre-Surgery Short-Term Administration of Letrozole in (Hormone-Positive) Breast Cancer. 激素阳性)乳腺癌患者手术前短期服用来曲唑可有效降低 Ki-67
Iranian Journal of Pathology Pub Date : 2024-01-01 Epub Date: 2023-12-29 DOI: 10.30699/IJP.2023.2002772.3118
Bita Eslami, Sadaf Alipour, Farzaneh Golfam, Behnaz Jahabnin, Ramesh Omranipour
{"title":"Effective Ki-67 Reduction by Pre-Surgery Short-Term Administration of Letrozole in (Hormone-Positive) Breast Cancer.","authors":"Bita Eslami, Sadaf Alipour, Farzaneh Golfam, Behnaz Jahabnin, Ramesh Omranipour","doi":"10.30699/IJP.2023.2002772.3118","DOIUrl":"10.30699/IJP.2023.2002772.3118","url":null,"abstract":"<p><strong>Background & objective: </strong>Antigen Ki-67 (histone-based nuclear protein) is a static marker of tumor cell proliferation and growth and is commonly measured to indicate the effect of treatment in breast cancer patients. This single-arm trial study aimed to evaluate the effect of short-term endocrine therapy (letrozole) on Ki-67 levels in menopausal women with early hormone-positive breast cancer who were referred to two university hospitals.</p><p><strong>Methods: </strong>Patients with a pre-treatment Ki67 of 5% or less were excluded from the study. Participants (n=25) received oral letrozole (2.5 mg daily) seven days before surgery. Ki-67% on both biopsies and the surgical specimens were measured and compared.</p><p><strong>Results and conclusion: </strong>The mean age of patients was 62±9.4 (48-83 years). Our result indicated that pre-surgery consumption of letrozole for hormone-positive breast cancer can significantly decrease the of Ki-67 labeling index (23.24±9.74 vs. 16.92±9.55, <i>P</i>=0.001 by paired t-test), with no drug-related adverse events.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 1","pages":"103-106"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141306998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of Expression of P16 in Premalignant and Malignant Lesions of Penis and Their Significance. 阴茎癌前病变和恶性病变中 P16 表达及其意义研究
Iranian Journal of Pathology Pub Date : 2024-01-01 Epub Date: 2024-03-29 DOI: 10.30699/IJP.2024.1998898.3092
Manish Shetty, Deepa Sowkur Anandarama Adiga, Chaithra G V
{"title":"Study of Expression of P16 in Premalignant and Malignant Lesions of Penis and Their Significance.","authors":"Manish Shetty, Deepa Sowkur Anandarama Adiga, Chaithra G V","doi":"10.30699/IJP.2024.1998898.3092","DOIUrl":"10.30699/IJP.2024.1998898.3092","url":null,"abstract":"<p><strong>Background & objective: </strong>Penile squamous cell carcinoma (SCC) is an extremely rare malignancy. It is usually caused by chronic human papillomavirus (HPV) 16 and HPV 18 infections. This study was conducted to investigate the immunohistochemical overexpression of p16, a surrogate marker for HPV, and to evaluate its usefulness as a potential diagnostic biomarker.</p><p><strong>Methods: </strong>In this cross-sectional prospective and retrospective cohort study, 56 penile squamous cell carcinoma (SCC) specimens and five penile premalignant specimens were evaluated in Kasturba Medical College, Mangalore, India, from January 2013- December 2018 in terms of clinical and histopathological features. Immunohistochemical expression for p16 in cases and controls was evaluated. Statistical comparison of p16 expression among clinical features, histological subtype, grade, and stages of tumor were done.</p><p><strong>Results: </strong>Analysis of the pattern of p16 staining showed diffuse and strong nuclear and cytoplasmic expression in 32.8% of the cases. There was a highly significant association (<i>P</i><0.001) of pattern of p16 expression among the HPV and non-HPV subtypes of penile carcinoma. p16 expression was not significantly associated with other prognostic parameters like site of the lesion, lymphovascular invasion, perineural invasion, histologic grade, and pathologic stage.</p><p><strong>Conclusion: </strong>Expression of p16 would be a useful tool in differentiation between the HPV-associated and non-HPV-associated subtypes of penile SCC that may be helpful in prediction of aggressiveness and invasive potential of the respective histologic subtypes.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 1","pages":"50-58"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Inflammatory Myofibroblastic Tumor of Rectosigmoid Junction: A Case Report and Review of the Literature. 小儿直肠乙状结肠交界处炎性肌母细胞瘤:病例报告和文献综述。
Iranian Journal of Pathology Pub Date : 2024-01-01 Epub Date: 2023-12-29 DOI: 10.30699/ijp.2024.2003653.3122
Mahsa Soti Khiabani, Maryam Monajemzadeh, Hojatollah Raji, Fatemeh Zamani, Mohammad Vaseie, Neda Pak
{"title":"Pediatric Inflammatory Myofibroblastic Tumor of Rectosigmoid Junction: A Case Report and Review of the Literature.","authors":"Mahsa Soti Khiabani, Maryam Monajemzadeh, Hojatollah Raji, Fatemeh Zamani, Mohammad Vaseie, Neda Pak","doi":"10.30699/ijp.2024.2003653.3122","DOIUrl":"10.30699/ijp.2024.2003653.3122","url":null,"abstract":"<p><p>The occurrence of rectosigmoid junction inflammatory myofibroblastic tumor (IMT) is uncommon in children. This is a rare form of mesenchymal tumor, belonging to the category of soft tissue tumors, and can be found at any anatomical site from the central nervous system to the gastrointestinal tract. Our patient was a 10-year-old male subject complaining of lack of defecation and constipation. The patient had decreased the frequency of defecation and constipation about two weeks before his referral and had not improved despite the use of laxatives. The abdomen was completely distended and there was no tenderness or guarding in the examination. Several airfluid levels are shown on the abdominal X-ray. In the ultrasound, free fluid was reported in the interlobular and pelvic spaces. The patient was transferred into the operating room. A tumor of the rectosigmoid junction was detected. Histopathologic studies showed evidence of IMT. IMT is a rare neoplasm of unknown origin, which may occur in various sites of the body. Complete surgical removal is usually curative, but early detection of recurrence is required. Treatment options include chemotherapy, radiation therapy, and immunotherapy. Further investigations are needed to improve the understanding and management of this rare tumor.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 1","pages":"132-136"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Secondary Bacterial Infections and Determination of Antibiogram Susceptibility Testing in Hospitalized Patients with COVID-19. 新型冠状病毒肺炎住院患者继发细菌感染评价及抗生素药敏试验测定
Iranian Journal of Pathology Pub Date : 2024-01-01 Epub Date: 2024-10-02 DOI: 10.30699/IJP.2024.2006587.3141
Tahmineh Mollasharifi, Mahmoud Zamani, Atoosa Gharib
{"title":"Evaluation of Secondary Bacterial Infections and Determination of Antibiogram Susceptibility Testing in Hospitalized Patients with COVID-19.","authors":"Tahmineh Mollasharifi, Mahmoud Zamani, Atoosa Gharib","doi":"10.30699/IJP.2024.2006587.3141","DOIUrl":"10.30699/IJP.2024.2006587.3141","url":null,"abstract":"<p><strong>Background & objective: </strong>COVID-19 is a global pandemic that has caused an increase in hospitalization rates and high mortality. Secondary bacterial infections in hospitalized patients are one of the common complications of this viral disease. Due to the increased prevalence of antibiotic resistance, treating these patients is challenging. Therefore, this study aimed to evaluate the secondary bacterial infection and antimicrobial sensitivity test in hospitalized patients with COVID-19 in a tertiary hospital.</p><p><strong>Methods: </strong>In this retrospective descriptive study, all patients with COVID-19 who were admitted to Shahid Modares Hospital (Tehran-Iran) from October 2020 to March 2021 with positive culture results for bacterial infections, were assessed. The significance level was lower than 0.05.</p><p><strong>Results: </strong>Ninety-seven patients with a mean age of 65.23 ± 16.72 years were assessed. The male patients accounted for 58.8% of the patients, while 41.2% were female. The ICU admitted patients with critical COVID-19 severity accounted for 59.8%, while 40.2% were hospitalized in the ward with a severe form of the disease. Age, length of hospitalization, and mortality rate were significantly higher in patients with ICU admission (all P-values<0.05). The most antibiotic-resistant bacteria were <i>Klebsiella pneumoniae</i> (32.98%). ICU admission showed a significantly higher rate in patients who were resistant to Cefotaxime, Ceftriaxone, Gentamicin, and Co-trimoxazole compared to the patients who were hospitalized in the ward (all P-values<0.05).</p><p><strong>Conclusion: </strong>Secondary bacterial infection in hospitalized patients with COVID-19 may lead to high mortality.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 4","pages":"392-399"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11872024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Oral Mucosal Micronucleus Testing an Effective Tool for Biomonitoring Pathology Laboratory Workers Chronically Exposed to Formalin? 口腔黏膜微核检测是长期暴露于福尔马林的病理实验室工作人员生物监测的有效工具吗?
Iranian Journal of Pathology Pub Date : 2024-01-01 Epub Date: 2024-10-15 DOI: 10.30699/ijp.2024.2017360.3224
Rosana Xavier, Andrea Cristina de Moraes Malinverni, Thiago Guedes Pinto, Fernando Cintra Magalhaes, Daniel Araki Ribeiro
{"title":"Is Oral Mucosal Micronucleus Testing an Effective Tool for Biomonitoring Pathology Laboratory Workers Chronically Exposed to Formalin?","authors":"Rosana Xavier, Andrea Cristina de Moraes Malinverni, Thiago Guedes Pinto, Fernando Cintra Magalhaes, Daniel Araki Ribeiro","doi":"10.30699/ijp.2024.2017360.3224","DOIUrl":"10.30699/ijp.2024.2017360.3224","url":null,"abstract":"","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 4","pages":"472-473"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11872036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信